Latest Health News

EVT Limited has announced a fully franked ordinary dividend of AUD 0.22 per share for the financial year ending June 30, 2025, payable in late September. This move underscores the company’s steady commitment to shareholder returns amid a dynamic entertainment sector.

Michael Hill International reported broadly flat FY25 financial results despite challenging retail conditions, with growth in Australia and Canada offset by ongoing difficulties in New Zealand. Strategic initiatives and early FY26 sales hint at cautious optimism.

Tasmea Limited has announced a fully franked ordinary dividend of AUD 0.06 per share for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 5% discount on new shares.

Haranga Resources has secured regulatory approvals and begun underground works at its Lincoln Gold Project, setting the stage for a maiden drilling campaign aimed at upgrading a significant historical gold resource to JORC standards.

DATA#3 Limited has announced a fully franked ordinary dividend of AUD 0.15 per share for the six months ending June 2025, signaling steady shareholder returns amid a stable financial period.

Tolu Minerals has completed a new access road to its Tolukuma Gold Mine, enabling vehicle access from Port Moresby and slashing operational costs by over 75%. This infrastructure milestone also opens vast new exploration opportunities and benefits local communities.

Bendigo and Adelaide Bank has announced a fully franked ordinary dividend of AUD 0.33 per share for the six months ending June 2025, with key dates set for early September and payment at the end of the month.

Vitura Health Limited has announced its third fully franked dividend of 0.2 cents per share following a profitable FY2025, reinforcing its unique position in the medicinal cannabis sector. Shareholders are invited to participate in a discounted Dividend Reinvestment Plan.

Vitura Health reported modest revenue growth but a robust 23.5% increase in EBITDA for FY2025, fueled by key acquisitions and expanding telehealth services. Despite margin pressures in medicinal cannabis, the company’s strategic reset under new leadership sets the stage for further growth.

Apiam Animal Health has entered a Process Deed granting Adamantem exclusivity to pursue a $0.88 per share acquisition proposal. The Independent Board Committee signals intent to recommend the deal, pending due diligence and shareholder approval.

Vitura Health reported a modest revenue increase to $124 million for FY2025, while net profit dipped 5.35% due to margin pressures and investment in new platforms. The company declared a fully franked dividend and highlighted growth in telehealth and medical services.

Praemium Limited reported robust FY25 results with revenue climbing 24.6% to $103 million and net profit after tax soaring 55% to $13.56 million, underpinned by strong growth in funds under administration and strategic product launches.